Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | -0.66% | -9.67% | -79.99% |
05-09 | Earnings Flash (CMAX) CAREMAX Reports Q1 Revenue $232.2M | MT |
04-01 | UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating | MT |
Evolution of the average Target Price on CareMax, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CareMax, Inc.
UBS | |
Piper Sandler | |
TD Cowen | |
Truist Securities | |
Jefferies & Co. | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- CMAX Stock
- Consensus CareMax, Inc.